After the first and second shots of the vaccine, the teenagers will stay in hospital, in an isolated ward, for three days. Later, they will have to visit the hospital at intervals to undergo tests.
Servier, a global independent pharmaceutical Group, and PRISM BioLab, a Japan based biotechnology company with proprietary small molecule drug discovery platform, “PepMetics™Technology”, today announced...
Avifavir® became the world’s first approved favipiravir-based drug for COVID-19 infection treatment and the first drug against COVID-19 authorized in Russia.